These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8453944

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Valproate metabolites in high-dose valproate plus phenytoin therapy.
    Sugimoto T, Muro H, Woo M, Nishida N, Murakami K.
    Epilepsia; 1996 Dec; 37(12):1200-3. PubMed ID: 8956852
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Associations between risk factors for valproate hepatotoxicity and altered valproate metabolism.
    Kondo T, Kaneko S, Otani K, Ishida M, Hirano T, Fukushima Y, Muranaka H, Koide N, Yokoyama M.
    Epilepsia; 1992 Dec; 33(1):172-7. PubMed ID: 1733753
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Children versus adults: pharmacokinetic and adverse-effect differences.
    Anderson GD.
    Epilepsia; 2002 Dec; 43 Suppl 3():53-9. PubMed ID: 12060006
    [Abstract] [Full Text] [Related]

  • 9. Is 2-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproate, responsible for valproate-induced hyperammonemia?
    Kondo T, Ishida M, Kaneko S, Hirano T, Otani K, Fukushima Y, Muranaka H, Koide N, Yokoyama M, Nakata S.
    Epilepsia; 1992 Dec; 33(3):550-4. PubMed ID: 1350534
    [Abstract] [Full Text] [Related]

  • 10. Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA.
    Gopaul S, Farrell K, Abbott F.
    Epilepsia; 2003 Mar; 44(3):322-8. PubMed ID: 12614387
    [Abstract] [Full Text] [Related]

  • 11. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults.
    König SA, Schenk M, Sick C, Holm E, Heubner C, Weiss A, König I, Hehlmann R.
    Epilepsia; 1999 Jul; 40(7):1036-40. PubMed ID: 10403231
    [Abstract] [Full Text] [Related]

  • 12. Valproate metabolites and hepatotoxicity in an epileptic population.
    Tennison MB, Miles MV, Pollack GM, Thorn MD, Dupuis RE.
    Epilepsia; 1988 Jul; 29(5):543-7. PubMed ID: 3137018
    [Abstract] [Full Text] [Related]

  • 13. Effect of valproate dose on formation of hepatotoxic metabolites.
    Anderson GD, Acheampong AA, Wilensky AJ, Levy RH.
    Epilepsia; 1992 Jul; 33(4):736-42. PubMed ID: 1628592
    [Abstract] [Full Text] [Related]

  • 14. Fatal liver failure in 16 children with valproate therapy.
    Scheffner D, König S, Rauterberg-Ruland I, Kochen W, Hofmann WJ, Unkelbach S.
    Epilepsia; 1988 Jul; 29(5):530-42. PubMed ID: 3137017
    [Abstract] [Full Text] [Related]

  • 15. [Valproate-associated hepatotoxicity--pathogenesis, clinical aspects, therapy and prevention].
    Siemes H, Nau H.
    Klin Padiatr; 1991 Jul; 203(6):411-9. PubMed ID: 1758143
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association of Valproic Acid and Its Main Metabolites' Plasma Concentrations with Clinical Outcomes among Epilepsy Patients: A 10-Year Retrospective Study Based on Therapeutic Drug Monitoring.
    Li RT, Chen ZY, Tang SY, Wen DS, Ren RN, Zhang XX, Liu SZ, Zhou S, Wang XD, Zhou LM, Huang M.
    Drug Metab Dispos; 2024 Feb 14; 52(3):210-217. PubMed ID: 38195521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.